US panel votes to authorize J&J COVID-19 vaccine booster

The committee members, convened by the Food and Drug Administration (FDA), agreed with the pharmaceutical company that safety and efficacy evidence favored a second dose. The recommendation may be tweaked further by the FDA ...

from Google Alert - Business https://ift.tt/3vhZAJI
The committee members, convened by the Food and Drug Administration (FDA), agreed with the pharmaceutical company that safety and efficacy evidence favored a second dose. The recommendation may be tweaked further by the FDA ... https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize